[{"orgOrder":0,"company":"Egetis Therapeutics","sponsor":"Premier Research Group | Egetis Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Rare Diseases and Disorders","country":"SWEDEN","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Tiratricol","moa":"NR1A","graph1":"Rare Diseases and Disorders","graph2":"Phase III","graph3":"Egetis Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Rare Diseases","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Egetis Therapeutics \/ Premier Research Group | Egetis Therapeutics","highestDevelopmentStatusID":"10","companyTruncated":"Egetis Therapeutics \/ Premier Research Group | Egetis Therapeutics"},{"orgOrder":0,"company":"Egetis Therapeutics","sponsor":"AnovoRx | Egetis Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Rare Diseases and Disorders","country":"SWEDEN","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Tiratricol","moa":"NR1A","graph1":"Rare Diseases and Disorders","graph2":"Phase III","graph3":"Egetis Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Rare Diseases","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Egetis Therapeutics \/ AnovoRx | Egetis Therapeutics","highestDevelopmentStatusID":"10","companyTruncated":"Egetis Therapeutics \/ AnovoRx | Egetis Therapeutics"}]

Find Clinical Drug Pipeline Developments & Deals for Tiratricol

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          June 22, 2023

                          Lead Product(s) : Tiratricol

                          Therapeutic Area : Rare Diseases and Disorders

                          Highest Development Status : Undisclosed

                          Sponsor : AnovoRx | Egetis Therapeutics

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Process Development
                          Not Confirmed
                          Process Development
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          October 13, 2022

                          Lead Product(s) : Tiratricol

                          Therapeutic Area : Rare Diseases and Disorders

                          Highest Development Status : Phase III

                          Sponsor : Premier Research Group | Egetis Therapeutics

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Lead Product(s) : Tiratricol

                          Therapeutic Area : Rare Diseases and Disorders

                          Study Phase : Phase II

                          Sponsor : Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Hormone

                          Upfront Cash : Inapplicable

                          March 24, 2015

                          Lead Product(s) : Tiratricol

                          Therapeutic Area : Rare Diseases and Disorders

                          Highest Development Status : Phase II

                          Sponsor : Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Hormone

                          Upfront Cash : Inapplicable

                          February 12, 2014

                          Lead Product(s) : Tiratricol

                          Therapeutic Area : Rare Diseases and Disorders

                          Highest Development Status : Phase II

                          Sponsor : ZonMw

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank